Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05329480 · ClinicalTrials.gov registry record · NA
Cardiac and Vascular Responses to Creatine Supplementation in Elderly Men
A NA study of Cardiac Function and Hemodynamics, sponsored by Radford University.
- Recruiting
- Registry status
- NA
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT05329480: Recruiting NA study of Cardiac Function and Hemodynamics, sponsored by Radford University.
NCT05329480 is a NA study of Cardiac Function and Hemodynamics that is actively recruiting participants, run by Radford University. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05329480, a NA study of Cardiac Function and Hemodynamics, is actively recruiting participants, sponsored by Radford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the impact of creatine supplementation alone or in combination with a moderate session of physical activity on vascular reactivity and heart hemodynamics in elderly men.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Maltodextrin
- DIETARY_SUPPLEMENT Creatine Monohydrate
Study Locations (1)
Virginia
- Carilion Roanoke Community Hospital - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2022-02-09 |
| Est. Completion | 2024-06 |
| Phase | NA |
What NCT05329480 shows while recruiting
NCT05329480 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiac Function and Hemodynamics appearing as the primary indexed condition, and to 2 interventions - of which Maltodextrin is the first listed.
NCT05329480 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05329480 about?
NCT05329480 is a clinical study titled "Cardiac and Vascular Responses to Creatine Supplementation in Elderly Men". The purpose of this study is to investigate the impact of creatine supplementation alone or in combination with a moderate session of physical activity on vascular reactivity and heart hemodynamics in elderly men.
What is the current status of trial NCT05329480?
This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2022-02-09. Estimated completion is 2024-06.
What conditions does trial NCT05329480 study?
This clinical trial studies the following conditions: Cardiac Function and Hemodynamics.
What interventions are being tested in trial NCT05329480?
The interventions under investigation include: Maltodextrin (DIETARY_SUPPLEMENT), Creatine Monohydrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05329480?
This trial is sponsored by Radford University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05329480 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05329480's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI